Assessing the impact of PD-1/PD-L1 inhibitors on health and budget in Belgium

被引：0
|
作者：
van Bavel, J. [1 ]
Lucherini, S. [2 ]
Vermeersch, S. [3 ]
Abreu, A. Bento [3 ]
Davies, N. [2 ]
Okhuoya, P. [2 ]
Pellisier, J. [4 ]
Roediger, A. [3 ]
机构：
[1] Merck USA, Charlotte, NC USA
[2] Adelphi Values UK, London, England
[3] MSD Belgium, Brussels, Belgium
[4] Merck USA, Chicago, IL USA
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2018年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：439 / 439
页数：1
相关论文
共 50 条
  • [31] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    RESPIROLOGY, 2023, 28 : 99 - 99
  • [32] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [33] PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
    Jelinek, T.
    Hajek, R.
    ONCOIMMUNOLOGY, 2016, 5 (12):
  • [34] Is it possible to rechallenge with PD-1/PD-L1 inhibitors after progression?
    Saleh, Khalil
    Khalifeh-Saleh, Nadine
    Kourie, Hampig Raphael
    IMMUNOTHERAPY, 2018, 10 (05) : 345 - 347
  • [35] PD-1/PD-L1 pathway inhibitors in advanced prostate cancer
    Velho, Pedro Isaacsson
    Antonarakis, Emmanuel S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 475 - 486
  • [36] A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors
    Lopez, Adriana T.
    Khanna, Trisha
    Antonov, Nina
    Audrey-Bayan, Claire
    Geskin, Larisa
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (06) : 664 - 669
  • [37] PD-1 and PD-L1 inhibitors in oesophago-gastric cancers
    Telli, Tugba Akin
    Bregni, Giacomo
    Camera, Silvia
    Deleporte, Amelie
    Hendlisz, Main
    Sclafani, Francesco
    CANCER LETTERS, 2020, 469 : 142 - 150
  • [38] Novel, small molecule inhibitors of PD-1/PD-L1 pathway
    Rastelli, Luca
    Rajagopal, Sridharan
    Gajendran, Chandru
    Sadhu, Naveen M.
    Mohd, Zainuddin
    Gosu, Ramachandraiah
    Friedmann-Morvinski, Dinorah
    Kandan, Saravanan
    Birudukota, Swarnakumari
    Srinivasan, S.
    Krishnakumar, V
    Wahid, Saif
    Siddiqui, Amir
    Viswakarma, Santosh
    Narayan, Ashwini
    Rudresh, G.
    Mullurwar, Sadanand R.
    Sher, Divsha
    Mansur, Shahar
    Sivanandhan, Dhanalakshmi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma
    Sonpavde, Guru
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11): : 1073 - 1074
  • [40] PD-1/PD-L1 inhibitors in haematological malignancies: update 2017
    Jelinek, Tomas
    Mihalyova, Jana
    Kascak, Michal
    Duras, Juraj
    Hajek, Roman
    IMMUNOLOGY, 2017, 152 (03) : 357 - 371
12345